SW – Smurfit WestRock plc

SW — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.89

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.42

EPS Last/This Y

0.65

EPS This/Next Y

1.35

Price

48.29

Target Price

56.2

Analyst Recom

1.16

Performance Q

15.97

Upside

-31.9%

Beta

0.93

Ticker: SW

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	SW	42.9	0.10	0.71	34968
2026-07-15	SW	43.57	0.11	0.02	35308
2026-07-16	SW	44.77	0.11	0.02	35330
2026-07-17	SW	44.31	0.11	0.38	35342
2026-07-20	SW	43.15	0.15	1.51	14675
2026-07-21	SW	43.06	0.16	0.00	14933
2026-07-22	SW	44.51	0.24	0.66	10486
2026-07-23	SW	43.71	0.25	9.50	10678
2026-07-24	SW	48.59	0.25	0.28	10697
2026-07-27	SW	50.08	0.21	0.01	11807
2026-07-28	SW	50.83	0.18	0.89	13822
2026-07-29	SW	48.28	0.25	1.03	16150
2026-07-30	SW	47.5	0.25	0.06	16101
2026-07-31	SW	45.98	0.25	0.13	16107
2026-08-03	SW	46.88	0.25	0.95	16011
2026-08-04	SW	48.49	0.26	3.82	14890
2026-08-05	SW	48.46	0.26	0.30	14828
2026-08-06	SW	46.94	0.26	0.04	14875
2026-08-07	SW	48.29	0.26	0.01	14872
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	SW	42.89	-14.7	1010.1	2.17
2026-07-15	SW	43.56	-14.7	1045.9	2.17
2026-07-16	SW	44.76	-18.0	1064.5	2.15
2026-07-17	SW	44.29	-18.0	1006.8	2.15
2026-07-20	SW	43.14	-18.6	983.7	2.15
2026-07-21	SW	43.07	-17.2	1024.3	2.15
2026-07-22	SW	44.50	-17.2	1086.6	2.15
2026-07-23	SW	43.68	-17.2	1001.6	2.15
2026-07-24	SW	48.58	-17.2	1210.5	2.15
2026-07-27	SW	50.08	-17.2	1077.0	2.15
2026-07-28	SW	50.80	-17.2	1053.0	2.15
2026-07-29	SW	48.26	-17.2	940.2	2.15
2026-07-30	SW	47.52	31.3	1008.5	2.16
2026-07-31	SW	45.97	31.3	992.0	2.16
2026-08-03	SW	46.88	6.9	1014.2	2.03
2026-08-04	SW	46.88	6.9	1014.2	2.03
2026-08-05	SW	48.46	13.8	986.8	1.99
2026-08-06	SW	46.94	13.8	936.6	1.99
2026-08-07	SW	48.29	12.5	1045.6	1.99
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	SW	-2.40	1.50	5.30
2026-07-15	SW	-2.40	1.50	5.30
2026-07-16	SW	-2.40	1.50	5.30
2026-07-17	SW	-2.40	1.50	5.30
2026-07-20	SW	-2.40	2.42	5.30
2026-07-21	SW	-2.40	2.42	5.30
2026-07-22	SW	-2.40	2.42	5.30
2026-07-23	SW	-2.45	2.42	5.30
2026-07-24	SW	-2.45	2.42	5.30
2026-07-27	SW	-2.45	2.29	4.89
2026-07-28	SW	-2.45	2.29	4.89
2026-07-29	SW	-2.45	2.29	4.89
2026-07-30	SW	-2.45	2.29	4.89
2026-07-31	SW	-2.45	2.29	4.89
2026-08-03	SW	-2.45	2.57	4.89
2026-08-04	SW	-2.55	2.57	4.89
2026-08-05	SW	-2.55	2.57	4.89
2026-08-06	SW	-2.55	2.57	4.89
2026-08-07	SW	-2.55	2.57	4.89
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.35

Avg. EPS Est. Current Quarter

0.65

Avg. EPS Est. Next Quarter

0.77

Insider Transactions

-2.55

Institutional Transactions

2.57

Beta

0.93

Average Sales Estimate Current Quarter

8223

Average Sales Estimate Next Quarter

8000

Fair Value

55.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.6

Max Drawdown 5-Year %

-54.4

Target Price

56.2

P/E

51.34

Forward P/E

14.13

PEG

0.59

P/S

0.81

P/B

1.4

P/Free Cash Flow

24.03

EPS

0.94

Average EPS Est. Cur. Y

1.99

EPS Next Y. (Est.)

3.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.59

Relative Volume

0.62

Return on Equity vs Sector %

-19.5

Return on Equity vs Industry %

0.3

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.23

EBIT Estimation

1045.6

◆ SW Consumer Cyclical

$48.28

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

6/15

Valuation

13/20

TP/AR

3/10

Options

6/10

RSI

56.8

Range 1M

65.2%

Sup Dist

3.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

18/30

Estimates

6/20

Inst/Vol

7/15

Options

10/10

EPS Yr

12.5%

EPS NY

48.2%

52W%

77.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +78.9% upside

Quality

3/30

Valuation

20/30

Growth

15/25

Stability

4/10

LT Trend

1/5

Upside

+78.9%

Quality

MoS

15%

SW — P/E HistoricalPackaging & Containers

Smurfit WestRock plc

Sector: Consumer Cyclical

Industry: Packaging & Containers

Employees: 96000

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Latest News

—

Caricamento notizie per SW…

stock quote shares SW – Smurfit WestRock plc Stock Price stock today

news today SW – Smurfit WestRock plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SW – Smurfit WestRock plc yahoo finance google finance

stock history SW – Smurfit WestRock plc invest stock market

stock prices SW premarket after hours

ticker SW fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	MURA	2.04	N/A	N/A	0
2026-07-15	MURA	2.04	N/A	N/A	0
2026-07-16	MURA	2.04	N/A	N/A	0
2026-07-17	MURA	2.04	N/A	N/A	0
2026-07-20	MURA	2.04	N/A	N/A	0
2026-07-21	MURA	2.04	N/A	N/A	0
2026-07-22	MURA	2.04	N/A	N/A	0
2026-07-23	MURA	2.04	N/A	N/A	0
2026-07-24	MURA	2.04	N/A	N/A	0
2026-07-27	MURA	2.04	N/A	N/A	0
2026-07-28	MURA	2.04	N/A	N/A	0
2026-07-29	MURA	2.04	N/A	N/A	0
2026-07-30	MURA	2.04	N/A	N/A	0
2026-07-31	MURA	2.04	N/A	N/A	0
2026-08-03	MURA	2.04	N/A	N/A	0
2026-08-04	MURA	2.04	N/A	N/A	0
2026-08-05	MURA	2.04	N/A	N/A	0
2026-08-07	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA — P/E HistoricalDrug Manufacturers - Specialty & Generic

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

MDT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.49

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

-0.2

EPS Last/This Y

2.2

EPS This/Next Y

0.46

Price

87.19

Target Price

97.35

Analyst Recom

1.71

Performance Q

11.8

Upside

-5.9%

Beta

0.57

Ticker: MDT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	MDT	79.31	0.70	0.49	220016
2026-07-15	MDT	80.46	0.69	0.55	225685
2026-07-16	MDT	83.56	0.70	0.29	230509
2026-07-17	MDT	83.18	0.70	0.36	233032
2026-07-20	MDT	83.29	0.69	0.25	196639
2026-07-21	MDT	82.34	0.65	0.80	207767
2026-07-22	MDT	81.89	0.65	0.45	215168
2026-07-23	MDT	82.03	0.65	1.83	218669
2026-07-24	MDT	83.22	0.69	1.89	229435
2026-07-27	MDT	84.21	0.64	1.17	209992
2026-07-28	MDT	86.91	0.63	0.44	212900
2026-07-29	MDT	87.53	0.64	0.49	218935
2026-07-30	MDT	85.72	0.65	0.89	223768
2026-07-31	MDT	85.4	0.66	0.28	225680
2026-08-03	MDT	86.71	0.66	0.07	219709
2026-08-04	MDT	86.2	0.68	0.29	216847
2026-08-05	MDT	85.99	0.67	2.02	220590
2026-08-06	MDT	85.91	0.71	0.58	229553
2026-08-07	MDT	87.16	0.71	0.26	230913
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	MDT	79.30	10.2	-633.6	5.95
2026-07-15	MDT	80.46	10.2	-271.1	5.95
2026-07-16	MDT	83.53	10.2	-141.9	5.95
2026-07-17	MDT	83.16	10.2	-377.5	5.95
2026-07-20	MDT	83.33	10.2	-342.4	5.95
2026-07-21	MDT	82.35	10.1	-413.8	5.95
2026-07-22	MDT	81.89	10.1	-382.2	5.95
2026-07-23	MDT	82.04	10.1	-340.6	5.95
2026-07-24	MDT	83.21	10.1	-270.0	5.95
2026-07-27	MDT	84.18	10.1	-286.3	5.95
2026-07-28	MDT	86.88	10.1	-176.5	5.95
2026-07-29	MDT	87.57	10.1	-307.2	5.95
2026-07-30	MDT	85.73	10.1	-466.2	5.95
2026-07-31	MDT	85.39	10.1	-371.4	5.95
2026-08-03	MDT	86.71	10.1	-264.9	5.95
2026-08-04	MDT	86.71	10.1	-264.9	5.95
2026-08-05	MDT	85.99	10.1	-364.6	5.95
2026-08-06	MDT	85.92	10.1	-355.9	5.95
2026-08-07	MDT	87.19	10.1	-268.9	5.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	MDT	-4.46	0.43	1.49
2026-07-15	MDT	-4.94	0.43	1.49
2026-07-16	MDT	-4.94	0.43	1.49
2026-07-17	MDT	-4.94	0.43	1.49
2026-07-20	MDT	-4.94	0.43	1.49
2026-07-21	MDT	-4.94	0.43	1.49
2026-07-22	MDT	-4.94	0.43	1.49
2026-07-23	MDT	-4.94	0.43	1.49
2026-07-24	MDT	-4.94	0.43	1.49
2026-07-27	MDT	-4.94	0.60	1.49
2026-07-28	MDT	-4.94	0.60	1.49
2026-07-29	MDT	-4.94	0.60	1.49
2026-07-30	MDT	-4.94	0.60	1.49
2026-07-31	MDT	-4.94	0.60	1.49
2026-08-03	MDT	-4.94	0.44	1.49
2026-08-04	MDT	-4.94	0.44	1.49
2026-08-05	MDT	-4.94	0.44	1.49
2026-08-06	MDT	-4.94	0.44	1.49
2026-08-07	MDT	-4.94	0.44	1.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.55

Avg. EPS Est. Current Quarter

1.39

Avg. EPS Est. Next Quarter

1.35

Insider Transactions

-4.94

Institutional Transactions

0.44

Beta

0.57

Average Sales Estimate Current Quarter

9547

Average Sales Estimate Next Quarter

9495

Fair Value

98.88

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

35.8

Max Drawdown 5-Year %

-45.1

Target Price

97.35

P/E

23.39

Forward P/E

13.63

PEG

1.72

P/S

3.07

P/B

2.26

P/Free Cash Flow

20.56

EPS

3.73

Average EPS Est. Cur. Y

5.95

EPS Next Y. (Est.)

6.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.2

Relative Volume

0.51

Return on Equity vs Sector %

-17.6

Return on Equity vs Industry %

-1.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-268.9

◆ MDT Healthcare

$87.16

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

8/25

Volume

11/15

Valuation

16/20

TP/AR

1/10

Options

2/10

RSI

61.9

Range 1M

77.6%

Sup Dist

2.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

13/30

Estimates

6/20

Inst/Vol

4/15

Options

7/10

EPS Yr

7.7%

EPS NY

7.5%

52W%

40.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +37.3% upside

Quality

10/30

Valuation

14/30

Growth

9/25

Stability

7/10

LT Trend

2/5

Upside

+37.3%

Quality

MoS

13%

MDT — P/E HistoricalMedical Devices

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT

Latest News

—

Caricamento notizie per MDT…

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

ITRM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.85

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

0.35

Price

0.03

Target Price

Analyst Recom

Performance Q

-91.64

Upside

N/A

Beta

3.42

Ticker: ITRM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ITRM	0.03	N/A	N/A	0
2026-07-15	ITRM	0.03	N/A	N/A	0
2026-07-16	ITRM	0.03	N/A	N/A	0
2026-07-17	ITRM	0.03	N/A	N/A	0
2026-07-20	ITRM	0.03	N/A	N/A	0
2026-07-21	ITRM	0.03	N/A	N/A	0
2026-07-22	ITRM	0.03	N/A	N/A	0
2026-07-23	ITRM	0.03	N/A	N/A	0
2026-07-24	ITRM	0.03	N/A	N/A	0
2026-07-27	ITRM	0.03	N/A	N/A	0
2026-07-28	ITRM	0.03	N/A	N/A	0
2026-07-29	ITRM	0.03	N/A	N/A	0
2026-07-30	ITRM	0.03	N/A	N/A	0
2026-07-31	ITRM	0.03	N/A	N/A	0
2026-08-03	ITRM	0.03	N/A	N/A	0
2026-08-04	ITRM	0.03	N/A	N/A	0
2026-08-05	ITRM	0.03	N/A	N/A	0
2026-08-07	ITRM	0.03	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.46

Institutional Transactions

Beta

3.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.72

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

337.7

Return on Equity vs Industry %

354.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.33

EBIT Estimation

9.2

No data found for ITRM

ITRM — P/E HistoricalBiotechnology

ITRM

Latest News

—

Caricamento notizie per ITRM…

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

AMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.45

Margin Of Safety %

-25

Put/Call OI Ratio

0.5

EPS Next Q Diff

0.06

EPS Last/This Y

1.73

EPS This/Next Y

0.01

Price

14.31

Target Price

Analyst Recom

Performance Q

-3.23

Upside

-299.2%

Beta

0.77

Ticker: AMRN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	AMRN	14.38	0.46	0.88	3195
2026-07-15	AMRN	14.46	0.46	2.52	3213
2026-07-16	AMRN	14.16	0.50	0.88	3365
2026-07-17	AMRN	13.98	0.50	0.68	3375
2026-07-20	AMRN	13.59	0.57	0.20	2504
2026-07-21	AMRN	13.95	0.53	0.07	2711
2026-07-22	AMRN	13.74	0.51	0.15	2798
2026-07-23	AMRN	13.64	0.50	0.00	2839
2026-07-24	AMRN	13.57	0.50	0.00	2857
2026-07-27	AMRN	13.81	0.50	0.09	2857
2026-07-28	AMRN	13.96	0.49	0.64	2885
2026-07-29	AMRN	14.26	0.49	0.63	2904
2026-07-30	AMRN	14.17	0.49	1.45	2950
2026-07-31	AMRN	14.26	0.49	19.67	2995
2026-08-03	AMRN	14.13	0.49	0.32	2997
2026-08-04	AMRN	14.72	0.49	0.16	3076
2026-08-05	AMRN	14.46	0.49	2.60	3110
2026-08-07	AMRN	14.29	0.50	0.50	3158
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	AMRN	14.39	-	-	-0.03
2026-07-15	AMRN	14.49	-	-	-0.03
2026-07-16	AMRN	14.19	-	-	-0.03
2026-07-17	AMRN	14.00	-	-	-0.03
2026-07-20	AMRN	13.61	-	-	-0.03
2026-07-21	AMRN	13.89	-	-	-0.03
2026-07-22	AMRN	13.80	-	-	-0.03
2026-07-23	AMRN	13.59	-	-	-0.03
2026-07-24	AMRN	13.53	-	-	-0.03
2026-07-27	AMRN	13.78	-	-	-0.03
2026-07-28	AMRN	13.98	-	-	-0.03
2026-07-29	AMRN	14.24	-	-	-0.03
2026-07-30	AMRN	14.20	-	-	-0.03
2026-07-31	AMRN	14.27	-	-	-0.03
2026-08-03	AMRN	14.10	-	-	-0.03
2026-08-04	AMRN	14.10	-	-	-0.03
2026-08-05	AMRN	14.45	-	-	-0.03
2026-08-06	AMRN	14.32	-	-	-0.03
2026-08-07	AMRN	14.31	-	-	-0.07
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	AMRN	0.00	0.35	2.60
2026-07-15	AMRN	0.00	0.35	2.60
2026-07-16	AMRN	0.00	0.35	2.60
2026-07-17	AMRN	0.00	0.35	2.60
2026-07-20	AMRN	0.00	0.36	2.60
2026-07-21	AMRN	0.00	0.36	2.60
2026-07-22	AMRN	0.00	0.36	2.60
2026-07-23	AMRN	0.00	0.36	2.60
2026-07-24	AMRN	0.00	0.36	2.60
2026-07-27	AMRN	0.00	0.32	2.46
2026-07-28	AMRN	0.00	0.32	2.46
2026-07-29	AMRN	0.00	0.32	2.46
2026-07-30	AMRN	0.00	0.32	2.46
2026-07-31	AMRN	0.00	0.32	2.46
2026-08-03	AMRN	0.00	0.00	2.45
2026-08-04	AMRN	0.00	0.00	2.45
2026-08-05	AMRN	0.00	0.00	2.45
2026-08-06	AMRN	0.00	0.00	2.45
2026-08-07	AMRN	0.00	0.00	2.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.07

Avg. EPS Est. Current Quarter

-0.02

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

Beta

0.77

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.74

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-93.1

Target Price

P/E

Forward P/E

PEG

P/S

1.62

P/B

0.68

P/Free Cash Flow

19.39

EPS

-1.3

Average EPS Est. Cur. Y

-0.07

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.57

Relative Volume

0.6

Return on Equity vs Sector %

-33.4

Return on Equity vs Industry %

-43.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

◆ AMRN Healthcare

$14.36

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

18/20

Pullback

17/25

Volume

9/15

Valuation

8/20

TP/AR

0/10

Options

7/10

RSI

48.7

Range 1M

40.1%

Sup Dist

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

14/30

Estimates

1/20

Inst/Vol

0/15

Options

7/10

EPS Yr

22.2%

EPS NY

14.3%

52W%

16.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -21.7% upside

Quality

5/30

Valuation

4/30

Growth

15/25

Stability

6/10

LT Trend

4/5

Upside

-21.7%

Quality

MoS

-25%

AMRN — P/E HistoricalBiotechnology

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

ALKS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.15

Margin Of Safety %

-22

Put/Call OI Ratio

0.52

EPS Next Q Diff

EPS Last/This Y

-0.2

EPS This/Next Y

0.55

Price

49.17

Target Price

55.98

Analyst Recom

1.67

Performance Q

38.9

Upside

-72.2%

Beta

0.31

Ticker: ALKS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	ALKS	51.61	0.70	0.20	24405
2026-07-15	ALKS	51.95	0.70	0.01	24565
2026-07-16	ALKS	51.98	0.69	0.18	24671
2026-07-17	ALKS	52.68	0.70	0.00	24548
2026-07-20	ALKS	51.75	0.76	0.05	21446
2026-07-21	ALKS	52.83	0.78	0.68	21609
2026-07-22	ALKS	52.56	0.66	0.45	21700
2026-07-23	ALKS	52.99	0.59	43.67	22138
2026-07-24	ALKS	52.86	0.57	0.03	21916
2026-07-27	ALKS	52.67	0.57	0.02	22042
2026-07-28	ALKS	50.62	0.56	0.71	22052
2026-07-29	ALKS	48.33	0.56	0.01	21962
2026-07-30	ALKS	50.1	0.54	1.60	22438
2026-07-31	ALKS	48.99	0.53	0.30	22740
2026-08-03	ALKS	49.53	0.53	5.31	22752
2026-08-04	ALKS	49.66	0.52	0.00	22644
2026-08-05	ALKS	49.63	0.52	0.08	22649
2026-08-07	ALKS	49.17	0.52	1.70	22605
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	ALKS	51.61	-72.7	-	0.98
2026-07-15	ALKS	51.96	-57.4	-	1.23
2026-07-16	ALKS	51.97	-57.4	-	1.23
2026-07-17	ALKS	52.71	-57.4	-	1.23
2026-07-20	ALKS	51.72	-57.4	-	1.23
2026-07-21	ALKS	52.88	-57.4	-	1.23
2026-07-22	ALKS	52.58	-57.4	-	1.23
2026-07-23	ALKS	53.01	-57.4	-	1.23
2026-07-24	ALKS	52.88	-57.4	-	1.23
2026-07-27	ALKS	52.67	-57.4	-	1.23
2026-07-28	ALKS	50.47	-57.4	-	1.23
2026-07-29	ALKS	48.32	-57.4	-	1.23
2026-07-30	ALKS	50.10	-57.4	-	1.23
2026-07-31	ALKS	48.99	-36.2	-	1.23
2026-08-03	ALKS	49.54	-36.2	-	1.23
2026-08-04	ALKS	49.54	-36.2	-	1.23
2026-08-05	ALKS	49.59	-62.1	-	1.27
2026-08-06	ALKS	48.41	-62.1	-	1.27
2026-08-07	ALKS	49.17	-62.1	-	1.27
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	ALKS	-4.13	-1.65	10.72
2026-07-15	ALKS	-4.13	-1.65	10.72
2026-07-16	ALKS	-4.13	-1.65	10.72
2026-07-17	ALKS	-4.13	-1.65	10.72
2026-07-20	ALKS	-4.13	-1.77	10.72
2026-07-21	ALKS	-4.13	-1.77	10.72
2026-07-22	ALKS	-4.13	-1.77	10.72
2026-07-23	ALKS	-4.13	-1.77	10.72
2026-07-24	ALKS	-4.13	-1.77	10.72
2026-07-27	ALKS	-4.13	-1.86	9.21
2026-07-28	ALKS	-4.13	-1.86	9.21
2026-07-29	ALKS	-4.13	-1.86	9.21
2026-07-30	ALKS	-4.13	-1.86	9.21
2026-07-31	ALKS	-4.10	-1.86	9.15
2026-08-03	ALKS	-2.33	-1.34	9.15
2026-08-04	ALKS	-3.73	-1.34	9.15
2026-08-05	ALKS	-3.73	-1.34	9.15
2026-08-06	ALKS	-3.73	-1.34	9.15
2026-08-07	ALKS	-3.73	-1.34	9.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.25

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

-3.73

Institutional Transactions

-1.34

Beta

0.31

Average Sales Estimate Current Quarter

465

Average Sales Estimate Next Quarter

473

Fair Value

38.59

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.7

Max Drawdown 5-Year %

-33.2

Target Price

55.98

P/E

127.71

Forward P/E

72.19

PEG

124.46

P/S

4.95

P/B

4.56

P/Free Cash Flow

37.22

EPS

0.39

Average EPS Est. Cur. Y

1.27

EPS Next Y. (Est.)

1.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.97

Relative Volume

0.44

Return on Equity vs Sector %

-23.7

Return on Equity vs Industry %

-3.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.29

EBIT Estimation

◆ ALKS Healthcare

$49.17

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

23/25

Volume

11/15

Valuation

10/20

TP/AR

3/10

Options

6/10

RSI

45.9

Range 1M

23%

Sup Dist

3.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

12/30

Estimates

8/20

Inst/Vol

4/15

Options

4/10

EPS Yr

-133.5%

EPS NY

242.3%

52W%

79.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +11.5% upside

Quality

8/30

Valuation

5/30

Growth

10/25

Stability

5/10

LT Trend

0/5

Upside

+11.5%

Quality

MoS

-22%

ALKS — P/E HistoricalBiotechnology

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2050

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS

Latest News

—

Caricamento notizie per ALKS…

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

No more stocks to show

SW – Smurfit WestRock plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MURA

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y